Pharmacolog implements change in management team – dismisses CEO
Pharmacolog i Uppsala AB (publ) announces that the Board of Directors has decided to immediately dismiss Per Persson from his role as CEO. At the same time, the company’s Chairman of the Board Erik Hedlund was appointed acting CEO of Pharmacolog.
The board has taken the decision based on its assessment that Per Persson is not the right person to lead the company. Erik Hedlund, with extensive experience in Pharmacolog, has now taken on the task of working with the way forward until a new CEO has been recruited. At the same time, the Board will complete the ongoing work with the company’s strategic planning.
Erik Hedlund is a very experienced leader in MedTech with experience from both operational management and board work in many companies, such as Siemens Medical, RaySearch Laboratories AB and C-Rad AB.
The recruitment process of a new permanent CEO has begun now.
As a result of Erik Hedlund being appointed acting CEO, the Board has appointed Board member Björn Varnestig as the new Chairman of the Board. Erik Hedlund remains on the Board as an ordinary member.
This disclosure contains information that Pharmacolog is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 30-03-2023 07:18 CET.
Pharmacolog provides solutions and products that enhance work efficiency and safety when preparing injectable medication. Our goal is to help prevent medication errors and ensure maximum medication efficacy when treating patients with powerful yet potentially harmful injectable drugs. Pharmacolog’s products help staff at pharmacies and hospital wards minimize the risk of errors in the compounding process. Furthermore, by verifying that drugs and narcotics used in surgery have not been tampered with, our solutions also make a vital contribution to preventing drug diversion.